NCT01573429View on ClinicalTrials.gov

Bisphenol A Controlled Exposure Study

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 18, 2012

Primary Completion Date

June 16, 2020

Study Completion Date

June 16, 2020

Conditions
Healthy Volunteers
Interventions
OTHER

deuterated-Bisphenol A (d-BPA)

The primary endpoints are key pharmacokinetic measurements of d-BPA and d-BPA conjugates in blood and urine over 6 days after a single dose of oral and/or ethanol solution dermal application and/or a carboxymethylcellulose suspension dermal application of a dose of 100 micro g/kg bw of d-BPA.

Trial Locations (1)

Unknown

NIEHS Clinical Research Unit (CRU), Research Triangle Park

All Listed Sponsors
lead

National Institute of Environmental Health Sciences (NIEHS)

NIH

NCT01573429 - Bisphenol A Controlled Exposure Study | Biotech Hunter | Biotech Hunter